Drug Type Monoclonal antibody |
Synonyms DC859A series, Research programme: anticancer therapeutics - Demuris |
Target |
Action inhibitors |
Mechanism FOXO1 inhibitors(Forkhead box protein O1 inhibitors), FOXO3 inhibitors(forkhead box O3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Discovery | United Kingdom | 01 Aug 2019 |